Tag! Purifying Proteins with Affinity Chromatography

What is now a standard protein laboratory technique began as an act of desperation.

Written byAileen Constans
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Abcam http://www.abcam.com

Active Motif http://www.activemotif.com

BD Biosciences-Clontech http://www.clontech.com

Bio-Rad Laboratories http://www.bio-rad.com

GE Healthcare http://www.amershambiosciences.com

IBA http://www.iba-go.com

Invitrogen http://www.invitrogen.com

Millipore http://www.millipore.com

New England Biolabs http://www.neb.com

Novagen http://www.novagen.com

Pierce Biotechnology http://www.piercenet.com

Promega http://www.promega.com

Qiagen http://www.qiagen.com

Sigma-Aldrich http://www.sigmaaldrich.com

Stratagene http://www.stratagene.com

Zymo Research http://www.zymoresearch.com

What is now a standard protein laboratory technique began as an act of desperation. In the late 1960s, two scientists in Christian Anfinsen's lab at the National Institute of Arthritis and Metabolic Diseases sought a way to purify large quantities of staphylococcal nuclease for enzyme-inhibitor interaction studies. At the time, the only chromatographic methods for purifying proteins took advantage of the physical properties of hydrophobicity, size, and charge, and single purification procedures required multiple steps.

Pedro Cuatrecasas, now at the University of California at San Diego, explains that the inspiration for a new method came when he was at home one day thinking about inhibitors. He realized if he were ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies